A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

The Global Matrigel Market is projected to grow from USD 85 Million in 2024 to USD 163.3 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The Global ...

Studying data on 59,433 cancer patients, they found significant differences between various ancestry groups in biomarker-based eligibility for treatment with precision oncology drugs, which are ...

James C Hamilton, the Chief Discovery/Trans Medicine of $ARWR ($ARWR), sold 21,758 shares of the company on 01-06-2025. We received data on the trade from a recent ...

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision ... of the tumor microenvironment, the team plans to test their approach using patient-derived ...

It shows the importance of discovery science in unraveling the complexities of cancer, so we can identify new ways to prevent, detect, and treat it.” OCCAMS consortium = the Oesophageal Cancer ...

Pancreatic cancer ... target for PDAC drug therapies, according to senior author Andrew Lowy, M.D., professor and division chief of surgical oncology at UC San Diego School of Medicine and ...

Fighting cancer ... discovery offers a new starting point in ccRCC." "It's the first suggestion that this would be potentially applicable to giving someone [diagnosed with ccRCC] one drug or ...

today announced that it has entered into a research collaboration with Pfizer to accelerate the discovery of novel precision allosteric therapeutics to address significant unmet medical needs.

Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision ... for solid tumors, is anticipated to enter the clinic in early 2025. Atavistik Bio is ...